Combination of Vascular Endothelial Growth Factor (VEGF) and Thymidine Phosphorylase (TP) to Improve Angiogenic Gene Therapy

Author： Bouïs Diane   Boelens Mirjam   Peters Erna   Koolwijk Pieter   Stob Gerrie   Kema Ido   Klinkenberg Marco   Mulder Nanno   Hospers Geke  

Publisher： Springer Publishing Company

ISSN： 0969-6970

Source： Angiogenesis, Vol.6, Iss.3, 2003-01, pp. : 185-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications

By Toi M.  

Angiogenesis, Vol. 1, Iss. 1, 1997-01 ,pp. : 71-83

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension

By  

Current Hypertension Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular endothelial growth factor (VEGF) in endometriosis

By Donnez J   Smoes P   Gillerot S   Casanas-Roux F   Nisolle M  

Human Reproduction, Vol. 13, Iss. 6, 1998-06 ,pp. : 1686-1690

Oxford University Press

Access to resources Recommend Favorite

Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF)

By Burns P.A.  

Angiogenesis, Vol. 6, Iss. 1, 2003-10 ,pp. : 73-77

Springer Publishing Company

Access to resources Recommend Favorite

Platelets and vascular endothelial growth factor (VEGF): A morphological and functional study

By Salgado R.  

Angiogenesis, Vol. 4, Iss. 1, 2001-01 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite